Papers
1
Total Citations
39
H-Index
1
About
Peter Hodder is a leading figure in the field of high-throughput screening (HTS) and assay development, with a particular focus on G protein-coupled receptors (GPCRs) and metabotropic glutamate receptors. His most cited work, "Identification of metabotropic glutamate receptor antagonists using an automated high-throughput screening system" (2003, 39 citations), exemplifies his pioneering contributions to the automation and miniaturization of drug discovery. By designing robust, cell-based assays and integrating them with robotic platforms, Hodder has enabled the rapid identification of novel pharmacological tools and therapeutic leads. His research has significantly advanced the understanding of allosteric modulation and receptor pharmacology, providing critical insights into neurological disorders. Beyond this landmark study, Hodder has been instrumental in developing innovative screening technologies, including multiplexed assays and label-free detection methods, which have been widely adopted in academic and industrial labs. With a career spanning over two decades, his work has garnered substantial recognition, shaping how researchers approach target validation and compound profiling. Hodder’s contributions continue to inspire a new generation of scientists in the fields of chemical biology and translational pharmacology.
Research Focus
Key Achievements
Top Papers
- 1